1
|
Levin JM, Holtzman SH, Maraganore J, Hastings PJ, Cohen R, Dahiyat B, Adams J, Adams C, Ahrens B, Albers J, Aspinall MG, Audia JE, Babler M, Barrett P, Barry Z, Bermingham N, Bloch S, Blum RI, Bolno PB, Bonney MW, Booth B, Bradbury DM, Brauer SK, Byers B, Cagnoni PJ, Cali BM, Ciechanover I, Clark C, Clayman MD, Cleland JL, Cobb P, Cooper R, Currie MG, Diekman J, Dobmeier EL, Doerfler D, Donley EL, Dunsire D, During M, Eckstein JW, Elenko E, Exter NA, Fleming JJ, Flesher GJ, Formela JF, Forrester R, Francois C, Franklin H, Freeman MW, Furst H, Gage LP, Galakatos N, Gallagher BM, Geraghty JA, Gill S, Goeddel DV, Goldsmith MA, Gowen M, Goyal V, Graney T, Grayzel D, Greene B, Grint P, Gutierrez-Ramos JC, Haney B, Ha-Ngoc T, Harris T, Hasnain F, Hata YS, Hecht P, Henshaw L, Heyman R, Hoppenot H, Horvitz HR, Hughes TE, Hutton WS, Isaacs ST, Jenkins A, Jonker J, Kaplan J, Karsen P, Keiper J, Kim J, Kindler J, King R, King V, Kjellson N, Koenig S, Koenig G, Kolchinsky P, Laikind P, Langer RB, Lee JJ, Leff JS, Leicher BA, Leschly N, Levin A, Levin M, Levine AJ, Levy A, Liu DR, Lodish HF, Lopatin U, Love TW, Macdonald G, Maderis GJ, Mahadevia A, Mahanthappa NK, Martin JF, Martin A, Martucci WE, McArthur JG, McCann CM, McCarthy SA, McDonough CG, Mendlein J, Miller L, Miralles D, Moch KI, More B, Myers AG, Narachi MA, Nashat A, Nelson W, Newell WJ, Olle B, Osborn JE, Owens JC, Pande A, Papadopoulos S, Parker HS, Parmar KM, Patterson MR, Paul SM, Perez R, Perry M, Pfeffer CG, Powell M, Pruzanski M, Purcell DJ, Rakhit A, Ramamoorthi K, Rastetter W, Rawcliffe AA, Reid LE, Renaud RC, Rhodes JP, Rieflin WJ, Robins C, Rocklage SM, Rosenblatt M, Rosin JG, Rutter WJ, Saha S, Samuels C, Sato VL, Scangos G, Scarlett JA, Schenkein D, Schreiber SL, Schwab A, Sekhri P, Shah R, Shenk T, Siegall CB, Simon NJ, Simonian N, Stein J, Su M, Szela MT, Taglietti M, Tandon N, Termeer H, Thornberry NA, Tolar M, Ulevitch R, Vaishnaw AK, VanLent A, Varsavsky M, Vlasuk GP, Vounatsos M, Waksal SG, Warma N, Watts RJ, Werber Y, Westphal C, Wierenga W, Williams DE, Williams LR, Xanthopoulos KG, Zohar D, Zweifach SS. US immigration order strikes against biotech. Nat Biotechnol 2017; 35:204-206. [PMID: 28267733 DOI: 10.1038/nbt.3824] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | | | | | | | - Ron Cohen
- Acorda Therapeutics, Inc., Ardsley, New York, USA
| | | | - Julian Adams
- Clal Biotechnology Industries (CBI), Cambridge, Massachusetts, USA
| | - Chris Adams
- Cydan Development Inc., Cambridge, Massachusetts, USA
| | | | - Jeff Albers
- Blueprint Medicines, Cambridge, Massachusetts, USA
| | | | - James E Audia
- Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
| | - Martin Babler
- Principia Biopharma, South San Francisco, California, USA
| | | | | | | | | | - Robert I Blum
- Cytokinetics, Inc., South San Francisco, California, USA
| | - Paul B Bolno
- Wave Life Sciences, Cambridge, Massachusetts, USA
| | | | - Bruce Booth
- Atlas Venture, Cambridge, Massachusetts, USA
| | | | | | - Brook Byers
- Biotech Venture Capitalist since 1978, Menlo Park, California, USA
| | - Pablo J Cagnoni
- Tizona Therapeutics, Inc., South San Francisco, California, USA
| | - Brian M Cali
- Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA
| | | | - Chip Clark
- Genocea Biosciences, Inc., Cambridge, Massachusetts, USA
| | | | | | - Paula Cobb
- Decibel Therapeutics, Cambridge, Massachusetts, USA
| | - Ron Cooper
- Albireo Pharma Inc., Boston, Massachusetts, USA
| | - Mark G Currie
- Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA
| | | | | | | | | | - Deborah Dunsire
- Southern Cross Biotech Consulting, Waltham, Massachusetts, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Simba Gill
- Evelo Biosciences, Cambridge, Massachusetts, USA
| | | | | | - Maxine Gowen
- Trevena Inc., King of Prussia, Pennsylvania, USA
| | | | - Tom Graney
- Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA
| | | | - Barry Greene
- Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA
| | - Paul Grint
- Regulus Therapeutics, San Diego, California, USA
| | | | - Bill Haney
- Dragonfly Therapeutics, Inc., Cambridge, Massachusetts, USA
| | | | - Tim Harris
- SV Life Sciences, Boston, Massachusetts, USA
| | | | | | - Peter Hecht
- Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA
| | | | | | | | - H Robert Horvitz
- Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
| | | | | | | | | | - Jeff Jonker
- NGM Biopharmaceuticals, Inc., South San Francisco, California, USA
| | - Jeff Kaplan
- Deerfield Management, New York, New York, USA
| | - Perry Karsen
- Intellia Therapeutics, Cambridge, Massachusetts, USA
| | - Jeb Keiper
- Nimbus Therapeutics, Cambridge, Massachusetts, USA
| | - Jean Kim
- Deerfield Management, New York, New York, USA
| | - Jeff Kindler
- Centrexion Therapeutics Inc., Boston, Massachusetts, USA
| | - Rachel King
- GlycoMimetics, Inc., Rockville, Maryland, USA
| | - Vanessa King
- Luc Therapeutics, Inc., Cambridge, Massachusetts, USA
| | | | | | | | | | | | - Robert Bob Langer
- Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
| | - John J Lee
- Decibel Therapeutics, Cambridge, Massachusetts, USA
| | | | - Bruce A Leicher
- Momenta Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
| | | | - Andrew Levin
- RA Capital Management, LLC, Boston, Massachusetts, USA
| | - Mark Levin
- Third Rock Ventures, Boston, Massachusetts, USA
| | | | - Alan Levy
- Chrono Therapeutics, Hayward, California, USA
| | - David R Liu
- Editas Medicine, Cambridge, Massachusetts, USA
| | | | | | - Ted W Love
- Global Blood Therapeutics, South San Francisco, California, USA
| | | | - Gail J Maderis
- Antiva Biosciences, Inc., South San Francisco, California, USA
| | | | | | - Joel F Martin
- Dauntless Pharmaceuticals, Inc., San Diego, California, USA
| | - Alex Martin
- Realm Therapeutics, Malvern, Pennsylvania, USA
| | | | | | | | | | | | | | - Larry Miller
- Macrolide Pharmaceuticals, Watertown, Massachusetts, USA
| | | | - Kenneth I Moch
- Cognition Therapeutics, Inc., Pittsburgh, Pennsylvania, USA
| | - Bob More
- Alta Partners, San Francisco, California, USA
| | | | | | - Amir Nashat
- Polaris Partners, Boston, Massachusetts, USA
| | - Wendy Nelson
- Boston Biotech Forum, Cambridge, Massachusetts, USA
| | | | - Bernat Olle
- Vedanta Biosciences, Inc., Cambridge, Massachusetts, USA
| | | | - Julia C Owens
- Millendo Therapeutics, Inc., Ann Arbor, Michigan, USA
| | - Atul Pande
- Verity BioConsulting, San Diego, California, USA
| | - Stelios Papadopoulos
- Biogen Inc., Exelixis Inc. &Regulus Therapeutics Inc., Great Neck, New York, USA
| | | | | | | | - Steve M Paul
- Voyager Therapeutics, Inc., Cambridge, Massachusetts, USA
| | - Rob Perez
- Life Science Cares, Boston, Massachusetts, USA
| | | | | | - Mike Powell
- Sofinnova Ventures, Menlo Park, California, USA
| | | | | | | | | | | | | | | | - Ron C Renaud
- RaNa Therapeutics, Cambridge, Massachusetts, USA
| | | | | | - Chad Robins
- Adaptive Biotechnologies, Seattle, Washington, USA
| | | | | | | | | | | | | | - Vicki L Sato
- Harvard Business School, Cambridge, Massachusetts, USA
| | | | | | | | | | | | | | - Rajeev Shah
- RA Capital Management, LLC, Boston, Massachusetts, USA
| | - Thomas Shenk
- Lewis Thomas Laboratory, Princeton, New Jersey, USA
| | | | - Nick J Simon
- Clarus Ventures LLC, South San Francisco, California, USA
| | | | - Jeff Stein
- Cidara Therapeutics, San Diego, California, USA
| | - Michael Su
- Decibel Therapeutics, Cambridge, Massachusetts, USA
| | - Mary T Szela
- Novelion Therapeutics, Vancouver, British Columbia, USA
| | | | | | - Henri Termeer
- Genzyme Corporation (former CEO), Cambridge, Massachusetts, USA
| | | | | | | | | | | | | | - George P Vlasuk
- Navitor Pharmaceuticals, Inc., Cambridge, Massachusetts, USA
| | | | | | - Neil Warma
- Opexa Therapeutics, Inc., The Woodlands, Texas, USA
| | - Ryan J Watts
- Denali Therapeutics Inc., South San Francisco, California, USA
| | | | | | | | | | | | | | | | | |
Collapse
|